Annual Retained Earnings
-$58.59 M
-$6.17 M-11.77%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual retained earnings is -$58.59 million, with the most recent change of -$6.17 million (-11.77%) on September 30, 2024.
- During the last 3 years, EDSA annual retained earnings has fallen by -$32.09 million (-121.13%).
- EDSA annual retained earnings is now -272406.98% below its all-time high of -$21.50 thousand, reached on April 30, 2008.
Performance
EDSA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$58.59 M
-$962.00 K-1.67%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly retained earnings is -$58.59 million, with the most recent change of -$962.00 thousand (-1.67%) on September 30, 2024.
- Over the past year, EDSA quarterly retained earnings has dropped by -$2.63 million (-4.70%).
- EDSA quarterly retained earnings is now -4474.93% below its all-time high of $1.34 million, reached on November 30, 2010.
Performance
EDSA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
EDSA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.8% | -4.7% |
| 3 y3 years | -121.1% | -15.6% |
| 5 y5 years | -770.0% | -15.6% |
EDSA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -121.1% | at low | -89.8% | at low |
| 5 y | 5-year | -770.0% | at low | -648.4% | at low |
| alltime | all time | <-9999.0% | at low | -4474.9% | at low |
Edesa Biotech Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -$58.59 M(+11.8%) | -$58.59 M(+1.7%) |
| Jun 2024 | - | -$57.63 M(+3.0%) |
| Mar 2024 | - | -$55.96 M(+3.4%) |
| Dec 2023 | - | -$54.10 M(+3.2%) |
| Sep 2023 | -$52.42 M(+19.0%) | -$52.42 M(+3.4%) |
| Jun 2023 | - | -$50.70 M(+4.1%) |
| Mar 2023 | - | -$48.71 M(+5.0%) |
| Dec 2022 | - | -$46.38 M(+5.3%) |
| Sep 2022 | -$44.04 M(+66.2%) | -$44.04 M(+6.8%) |
| Jun 2022 | - | -$41.23 M(+16.3%) |
| Mar 2022 | - | -$35.44 M(+14.8%) |
| Dec 2021 | - | -$30.87 M(+16.5%) |
| Sep 2021 | -$26.50 M(+101.7%) | -$26.50 M(+16.2%) |
| Jun 2021 | - | -$22.81 M(+26.4%) |
| Mar 2021 | - | -$18.05 M(+14.4%) |
| Dec 2020 | - | -$15.78 M(+20.2%) |
| Sep 2020 | -$13.13 M(+95.0%) | -$13.13 M(+18.3%) |
| Jun 2020 | - | -$11.10 M(+19.1%) |
| Mar 2020 | - | -$9.32 M(+19.0%) |
| Dec 2019 | - | -$7.83 M(+35.4%) |
| Sep 2019 | -$6.73 M(-86.6%) | - |
| Jun 2019 | - | -$5.78 M(-89.2%) |
| Mar 2019 | - | -$53.49 M(+3.2%) |
| Dec 2018 | - | -$51.84 M(+2.8%) |
| Sep 2018 | -$50.43 M(+11.1%) | -$50.43 M(+2.3%) |
| Jun 2018 | - | -$49.30 M(+2.4%) |
| Mar 2018 | - | -$48.15 M(+2.9%) |
| Dec 2017 | - | -$46.79 M(+3.1%) |
| Sep 2017 | -$45.39 M | -$45.39 M(+2.8%) |
| Jun 2017 | - | -$44.17 M(+2.8%) |
| Mar 2017 | - | -$42.95 M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | - | -$41.85 M(+3.7%) |
| Sep 2016 | -$40.36 M(+14.2%) | -$40.36 M(+3.4%) |
| Jun 2016 | - | -$39.02 M(+3.2%) |
| Mar 2016 | - | -$37.83 M(+2.3%) |
| Dec 2015 | - | -$36.97 M(+4.6%) |
| Sep 2015 | -$35.34 M(+8.7%) | -$35.34 M(+4.5%) |
| Jun 2015 | - | -$33.80 M(-1.4%) |
| Mar 2015 | - | -$34.26 M(+1.3%) |
| Dec 2014 | - | -$33.84 M(+0.6%) |
| Sep 2014 | -$32.49 M(-3.4%) | - |
| Aug 2014 | -$33.62 M(+33.5%) | -$33.62 M(+15.9%) |
| May 2014 | - | -$29.01 M(-5.9%) |
| Feb 2014 | - | -$30.82 M(+0.8%) |
| Nov 2013 | - | -$30.58 M(+21.5%) |
| Aug 2013 | -$25.18 M(+144.1%) | -$25.18 M(+58.4%) |
| May 2013 | - | -$15.90 M(+8.0%) |
| Feb 2013 | - | -$14.73 M(+32.9%) |
| Nov 2012 | - | -$11.08 M(+7.4%) |
| Aug 2012 | -$10.32 M(+101.5%) | -$10.32 M(+7.7%) |
| May 2012 | - | -$9.58 M(+13.3%) |
| Feb 2012 | - | -$8.46 M(+11.1%) |
| Nov 2011 | - | -$7.61 M(+48.7%) |
| Aug 2011 | -$5.12 M(+236.1%) | -$5.12 M(-26.6%) |
| May 2011 | - | -$6.97 M(+22.9%) |
| Feb 2011 | - | -$5.68 M(-523.8%) |
| Nov 2010 | - | $1.34 M(-187.9%) |
| Aug 2010 | -$1.52 M(+1497.0%) | -$1.52 M(+327.7%) |
| May 2010 | - | -$356.20 K(+114.4%) |
| Jan 2010 | - | -$166.10 K(+7.3%) |
| Oct 2009 | - | -$154.80 K(+62.3%) |
| Apr 2009 | -$95.40 K(+343.7%) | -$95.40 K |
| Apr 2008 | -$21.50 K | - |
FAQ
- What is Edesa Biotech annual retained earnings?
- What is the all time high annual retained earnings for Edesa Biotech?
- What is Edesa Biotech annual retained earnings year-on-year change?
- What is Edesa Biotech quarterly retained earnings?
- What is the all time high quarterly retained earnings for Edesa Biotech?
- What is Edesa Biotech quarterly retained earnings year-on-year change?
What is Edesa Biotech annual retained earnings?
The current annual retained earnings of EDSA is -$58.59 M
What is the all time high annual retained earnings for Edesa Biotech?
Edesa Biotech all-time high annual retained earnings is -$21.50 K
What is Edesa Biotech annual retained earnings year-on-year change?
Over the past year, EDSA annual retained earnings has changed by -$6.17 M (-11.77%)
What is Edesa Biotech quarterly retained earnings?
The current quarterly retained earnings of EDSA is -$58.59 M
What is the all time high quarterly retained earnings for Edesa Biotech?
Edesa Biotech all-time high quarterly retained earnings is $1.34 M
What is Edesa Biotech quarterly retained earnings year-on-year change?
Over the past year, EDSA quarterly retained earnings has changed by -$2.63 M (-4.70%)